Bellicum Pharmaceuticals to Present New Translational Data for BPX-601 at ASCO 2020 Gastrointestinal Cancers Symposium

NEXT STORY
TYME and The Joseph Ahmed Foundation Announce First Patient Dosed in Phase II (HopES) Trial Evaluating the Potential Benefits of Oral SM-88 for Patients with High-Risk Sarcomas
PREV STORY
Phoenix Children’s Is the First-Ever Health System in the U.S to Use Medtronic Stealth Autoguide™ Cranial Robotic Guidance Platform for Neurosurgery
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cyclacel Pharmaceuticals Reports Second Quarter 2018 Financial Results

Conference Call Scheduled August 9, 2018 at 4:30 p.m. EDTBERKELEY HEIGHTS, N.J., Aug. 09, ...

author_avatar
NASDAQ Market News

First Wave BioPharma Forms Steering Committee for Phase 2a PASSPORT Clinical Trial to Evaluate FW-ICI-AC in Cancer Patients with Immune Checkpoint Inhibitor-Associated Colitis

author_avatar
NASDAQ Market News

Quanta Strengthens Management Team in Preparation for Launch of SC+

author_avatar
NASDAQ Market News